Dr. Stanley Schwartz is an Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa.  Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago. 

Dr. Schwartz actively lectures nationally, as well as internationally, about diabetes and its treatment. In the past 6 years he has been a speaker in Turks/Caicos, Istanbul, Switzerland , Belgium, Tunisia ,Spain , 11 cities in China, Phillipines (AACE,Phillipine Endo. Society), Israel, Singapore and AACE 2011/2014,ADA 2014- (2015) and in October, 2016 at Korean Diabetes Assoc. meeting.  He has authored numerous articles in peer-reviewed scientific journals and has been a lead or co-investigator for many clinical trials  (DCCT-EDIC, LOOK AHEAD).  He has created a call for minimizing insulin use in ‘Type 2 ‘ DM  and proposed a New Classification for All Diabetes and presented it in Jerusalem, at ADA 2014 and ADA/JDRF symposium 2015 and now published in Diabetes Care,  which has garnered much attention.

Since leaving Penn, he has received an R-01 from the NIH for studying the Genes related to LADA (with 2 articles published), written 3 book chapters, had posters at 2012 AACE, ADA and EASD in 2014 and 2015), has had 28 peer-reviewed article’s published (incretins in Hospital ,  hypoglycemia, a critique of ADA DM guideline , incretins in NODAT , weight reduction in DM, the incretin story), and most recently A Unified Pathophysiologic Construct of DM and its Complications..  He is  an author of the Self-Assessment Program of the American Diabetes Assoc (2007 and 2008) , the 2009/2010 AACE  Diabetes Guidelines, and slide modules  for primary care for AACE, 2011 and 2013, and Diabetes in Control 2013-2016 . He  is a member or fellow of international, national, and local professional societies including an Overseas Fellow of the  Royal Society of Medicine (London), European Association for the Study of Diabetes (EASD), the International Diabetes Federation (IDF), the American Diabetes Association (ADA), the American Endocrine Society (ES), College of Physicians in Philadelphia, and the American College of Physicians (ACP). He’s been elected by his peers for inclusion in Best Doctors in America® from 1996 to 2016.  Though he does some research and teaches a great deal, most  of his  time is  spent caring  for  patients.

 

Endocrinology and metabolism, Diabetes Care